Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 28, 2025, Ligand Pharmaceuticals (LGND) has a market cap of $2.09 billion USD. According to our data, Ligand Pharmaceuticals is ranked No.3963 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 28, 2025 | $2.09 B |
3.37%
|
| Dec 31, 2024 | $2.02 B |
50.03%
|
| Dec 29, 2023 | $1.35 B |
6.92%
|
| Dec 30, 2022 | $1.26 B |
-30.67%
|
| Dec 31, 2021 | $1.82 B |
55.31%
|
| Dec 31, 2020 | $1.17 B |
-4.64%
|
| Dec 31, 2019 | $1.23 B |
-23.15%
|
| Dec 31, 2018 | $1.60 B |
-0.90%
|
| Dec 29, 2017 | $1.61 B |
34.76%
|
| Dec 30, 2016 | $1.20 B |
-6.28%
|
| Dec 31, 2015 | $1.28 B |
103.76%
|
| Dec 31, 2014 | $0.63 B |
1.16%
|
| Dec 31, 2013 | $0.62 B |
153.62%
|
| Dec 31, 2012 | $0.24 B |
74.73%
|
| Dec 30, 2011 | $0.14 B |
33.07%
|
| Dec 31, 2010 | $0.11 B |
-31.49%
|
| Dec 31, 2009 | $0.15 B |
-20.80%
|
| Dec 31, 2008 | $0.19 B |
-43.27%
|
| Dec 31, 2007 | $0.34 B |
-41.17%
|
| Dec 29, 2006 | $0.58 B |
-1.79%
|
| Dec 30, 2005 | $0.59 B |
-4.21%
|
| Dec 31, 2004 | $0.62 B |
-20.76%
|
| Dec 31, 2003 | $0.78 B |
173.56%
|
| Dec 31, 2002 | $0.28 B |
-70.00%
|
| Dec 31, 2001 | $0.95 B |
27.86%
|
| Dec 29, 2000 | $0.74 B |
8.74%
|
| Dec 31, 1999 | $0.68 B |
10.75%
|
| Dec 31, 1998 | $0.62 B |
-9.71%
|
| Dec 31, 1997 | $0.68 B |
-13.45%
|
| Dec 31, 1996 | $0.79 B |
38.37%
|
| Dec 29, 1995 | $0.57 B |
30.30%
|
| Dec 30, 1994 | $0.44 B |
-29.79%
|
| Dec 31, 1993 | $0.62 B |
11.90%
|
| Dec 31, 1992 | $0.56 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$150.87 B |
0.008 M
|
USA
|
 Gilead Sciences
GILD
|
$132.33 B |
3.883 B
|
USA
|
 Biogen
BIIB
|
$17.49 B |
98.043 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$65.57 B |
0.780 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$126.96 B |
0.004 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$12.14 B |
-0.000 M
|
USA
|
 Incyte
INCY
|
$11.45 B |
0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$32.56 B |
-0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.72 B |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.99 B |
0.128 B
|
USA
|
 Moderna
MRNA
|
$10.59 B |
65.708 M
|
USA
|
 Novavax
NVAX
|
$1.14 B |
64.339 M
|
USA
|
 Blueprint Medicines
BPMC
|
$5.60 B |
0.000 M
|
USA
|
 Ultragenyx
RARE
|
$3.58 B |
0.000 M
|
USA
|
| Market Cap | = | LGND Stock Price | * | LGND Shares Outstanding |
| = | $108.07 | * | 19.28 M | |
| = | $2.09 B |